The new Alzheimer’s drug that could break Medicare

    Medicare, the federal health insurance program that covers Americans over 65, is facing an impossible dilemma: Should it cover a new and expensive medication for Alzheimer’s disease, which afflicts 6 million Americans and for which there is no existing treatment, even though the drug might not actually work? It is an enormous question. Alzheimer’s patients…

    Read More